@article{257b4899c0284fb79767b9949fdc3497,
title = "Anti-JC-virus antibody prevalence in a German MS cohort",
author = "Clemens Warnke and Thomas Dehmel and Anita Posevitz-Fejf{\'a}r and Andrew Chan and Achim Berthele and Stephan Schmidt and Judith Haas and Kronsbein, \{Helena C.\} and Florian Seitz and Bj{\"o}rn Tackenberg and Mathias M{\"a}urer and Kathrin Gerbershagen and Volker Limmroth and Ortwin Adams and Hartung, \{Hans Peter\} and Ralf Gold and Bernhard Hemmer and Heinz Wiendl and Kieseier, \{Bernd C.\}",
note = "Funding Information: This work was supported by grants from the German Ministry for Education and Research (BMBF, {\textquoteleft}German Competence Network Multiple Sclerosis{\textquoteright} (KKNMS), Natalizumab-Pharmakovigilanzstudie, grant number 01GI1002). CW is supported by an ECTRIMS fellowship stipend. Funding Information: TD, AP-F, CW, HCK and OA declare no conflicts of interest. AB, BCK, H-PH, VL, JH, SS, RG and HW have received honoraria for lecturing, travel expenses for attending meetings, and financial support for research from Bayer Health Care, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis, and TEVA Neuroscience. BT has received honoraria for lecturing, travel expenses for attending meetings, and financial support for research from Bayer Health Care, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis and TEVA Neuroscience. MM has received honoraria for lecturing, travel expenses for attending meetings, and financial support for research from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis, Talecris and TEVA Neurosciences. AC has received research support from Bayer Vital, Biogen Idec, Merck Serono and Novartis. Has received compensation for advisory boards or lectures from Bayer Vital, Biogen Idec, Merck Serono, Novartis, Sanofi-Aventis and Teva. KG received travel expenses and honoraria as speaker from Bayer Health Care and Sanofi Aventis. BH has served on scientific advisory boards for Bayer Schering Pharma, Biogen Idec, Roche, Novartis and Merck Serono; serves as a consultant for Gerson Lehrman Group; and has received research support from Bayer Schering Pharma, Biogen Idec, Roche, Novartis, Merck Serono, Metanomics Health GmbH, Protagen AG, Deutsche Forschungsgemeinschaft (DFG), Bundesministerium f{\"u}r Bildung und Forschung (BMBF) and Hertie Foundation.",
year = "2012",
month = jul,
doi = "10.1177/1352458511429955",
language = "English",
volume = "18",
pages = "1054--1055",
journal = "Multiple Sclerosis Journal",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "7",
}